Mw. Epperly et al., Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation, INT J CANC, 96(4), 2001, pp. 221-231
Intraesophageal administration of manganese superoxide dismutase-plasmid/li
posome (MnSOD-PL) prior to single fraction radiation has been shown to prot
ect mice from lethal esophagitis. In our study, C3H/HeNsd mice received fra
ctionated radiation in two protocols: (i) 18 Gy daily for four days with Mn
SOD-PL administration 24 hr prior to the first and third fraction, or (ii)
12 Gy daily for six days with MnSOD-PL 24 hr prior to the first, third, and
fifth fraction. Control radiated mice received either no liposomes only or
LacZ (bacterial beta -galactosidase gene)-plasmid/liposome (LacZ-PL) by th
e same schedules. We measured thiol depletion and lipid peroxidation (LP) i
n whole esophagus and tested the effectiveness of a new plasmid, hemaggluti
nin (RA) epitope-tagged MnSOD (HA/MnSOD). In fractionation protocols, mice
receiving MnSOD-PL, but not LacZ-PL (200 mul of plasmid/liposomes containin
g 200 mug of plasmid DNA), showed a significant reduction in morbidity, dec
reased weight loss, and improved survival. Four and seven days after 37 Gy
single fraction radiation, the esophagus demonstrated a significant increas
e in peroxidized lipids and reduction in overall antioxidant levels, reduce
d thiols, and decreased glutathione (GSH). These reductions were modulated
by MnSOD-PL administration. The HA-MnSOD plasmid product was detected in th
e basal layers of the esophageal epithelium 24 hr after administration and
provided significant radiation protection compared to glutathione peroxidas
e-plasmid/liposome (GPX-PL), or liposomes containing MnSOD protein, vitamin
E, co-enzyme Q10, or 21-aminosteroid. Thus, MnSOD-PL administration signif
icantly improved tolerance to fractionated radiation and modulated radiatio
n effects on levels of GSH and lipid peroxidation (LP). These studies provi
de further support for translation of MnSOD-PL treatment into human esophag
eal radiation protection. (C) 2001 Wiley-Liss, Inc.